Agilent & Virscidian Connect OpenLab CDS & Analytical Studio

Agilent Technologies, Inc. and Virscidian, LLC today announced an expanded collaboration to enhance interoperability between Agilent OpenLab CDS and Virscidian Analytical Studio. The solution enables scientists to seamlessly access chromatography data and orchestrate high-throughput workflows, including purification.  It delivers greater efficiency for pharma and biopharma customers engaged in drug discovery, medicinal chemistry, and high-throughput purification processes, where operational performance is critical.

Under the collaboration, the companies are co-developing an integrated approach that will enable OpenLab CDS and Analytical Studio software to be connected via an integrated application programming interface (API) that facilitates real-time communication and streamlined data sharing between the two platforms. This new integration will create a more cohesive user experience, reducing manual intervention in experiments, and maximizing the utility of the hardware.

"We are excited to announce this strategic partnership between Agilent and Virscidian, combining our strengths to deliver enhanced value and innovative solutions that directly benefit our customers," said John Beary, AVP Marketing, Productivity Solutions Division at Agilent.

Mark Bayliss, CTO at Virscidian, commented:

“Scientists should be empowered with the flexibility to do their work efficiently and in a fully integrated way, especially in complex workflows like purification.  By partnering with Agilent, we’re simplifying data access and workflow automation so teams can move faster with confidence.  The API integration directions are about reducing difficulties today and unlocking more dynamic workflows in the future.  With this collaboration, customers will have unrestricted use of their acquired data with neither Virscidian nor Agilent placing limitations on where it can be copied, used, or processed.”

‍

 About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

About Virscidian

Virscidian delivers decision-driven solutions that increase productivity and accelerate outcomes across pharmaceutical, biotechnology, and agriscience R&D value chains. Virscidian’s scientific analytical desktop and enterprise software helps customers, independently of the vendor instrumentation, perform experiments such as automated reaction screening, end-to-end purification, affinity selection by mass spectrometry, compound quality control, and other high-throughput analytical techniques. Their solutions transform raw data into actionable intelligence that improves productivity and the quality of results, enabling chemists and project teams to make complex decisions from large amounts of data confidently. Their solutions are easily integrated and provide critical decisions to drive some of the most sophisticated automation platforms in the world.  Virscidian was acquired by Dotmatics in 2024, which is now part of Siemens.  Information about Virscidian is available at www.virscidian.com.  Follow Virscidian on LinkedIn.

Media Contacts:

Agilent: Kate Coyle
kate.coyle@agilent.com

Virscidian/Dotmatics: Maggie Quale
maggie.quale@dotmatics.com